BioSpace News Archive

Business

Vaccitech and Oxford University announce landmark partnership with AstraZeneca for the development and large-scale distribution of the COVID-19 vaccine candidate

Vaccitech Ltd and the University of Oxford announce an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the University.

May 4, 2020
·
9 min read
Drug Development

Galecto Presents GB0139 Preclinical and Clinical Data on Anti-Fibrotic Activity as Online Experimental Biology 2020 Poster

Galecto, Inc. announced new data describing the preclinical and clinical evidence for anti-fibrotic activity of its lead compound GB0139, in an abstract for the Experimental Biology 2020 conference.

May 4, 2020
·
2 min read
Study Finds Noninvasive, Continuous Masimo PVi® Monitoring More Valuable Than Central Venous Pressure Measurement for Guiding Fluid Management During Surgery

Masimo announced the findings of a study published in the Journal of Anesthesiology and Reanimation Specialists’ Society in which researchers compared two methods of intraoperative fluid management during orthopedic spinal surgery, including Masimo PVi®.

May 4, 2020
·
8 min read
Business

SciBase and Advanced Dermatology and Cosmetic Surgery Group Partner to Advance Skin Cancer Detection in US’ Largest Dermatology Network

SciBase announced, on “Melanoma Monday”, that they have entered into a collaboration agreement with Advanced Dermatology and Cosmetic Surgery - the premier dermatology network in the US with over 150 practices.

May 4, 2020
·
4 min read
Business

HORAMA Appoints Industry Veteran Ian Catchpole as Chief Scientific Officer

HORAMA, a clinical stage gene therapy company in ophthalmology, announced the appointment of Dr. Ian Catchpole as its Chief Scientific Officer.

May 4, 2020
·
3 min read
Policy

Stallergenes Greer Submits a Marketing Authorisation Application in Europe for Its Sublingual House Dust Mite Allergen Immunotherapy Tablet

Stallergenes Greer, a biopharmaceutical company specialising in treatments for respiratory allergies, announces the submission of a marketing authorisation application for STAGR320, its sublingual house dust mite immunotherapy tablet, via a European decentralized procedure.

May 4, 2020
·
4 min read
Business

Utrecht University, Erasmus Medical Center and Harbour BioMed Researchers Report Discovery of Antibody that Blocks Novel Coronavirus SARS-CoV-2 Infection in Cells

Research Published in Nature Communications is Initial Step Towards Developing Fully Human Antibody Therapeutics and Diagnostics for Respiratory Disease COVID-19

May 4, 2020
·
5 min read
Business

Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer

Hovione announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer, effective May 1st, 2020.

May 4, 2020
·
2 min read
Business

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020

Amphastar Pharmaceuticals, Inc. announced that the Company will release results for its first quarter of 2020 ended March 31, 2020, after the market closes on Thursday, May 7th, 2020, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time..

May 4, 2020
·
2 min read
Deals

Oragenics Acquires Noachis Terra Inc., To Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing “Spike Protein”

Oragenics, Inc.,, announced its acquisition of Noachis Terra Inc., following its entry into a stock purchase agreement, to develop and commercialize TerraCoV2, a vaccine candidate which could provide specific immunity from the novel coronavirus, the root cause of coronavirus disease 2019.

May 4, 2020
·
8 min read